The PI3K/AKT signaling pathway plays a crucial role in promoting tumorigenesis, aggressiveness, and metastasis in cancer cells, making it a potential therapeutic target, particularly in metastatic osteosarcoma. This evidence concerns the gene AKT1 and cancer.